Clinically, elevated circulating TNF-α predicts poor prognosis in colorectal, breast, and lung cancers, while pilot studies in HF cohorts link higher TNF-α concentrations to cachexia, sarcopaenia, and adverse ventricular remodeling (15–17). The gene discussed is TNF; the disease is Cachexia.